Keytruda vs Dupixent
Side-by-side drug price comparison from Medicare Part D data
Verdict
Dupixent costs 84% less per claim than Keytruda ($2819.00 vs $18176.00). Neither drug has a generic alternative available. Total Medicare spending: Keytruda at $7.2B vs Dupixent at $4.4B.
| Metric | Keytruda | Dupixent |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $18,176 | $2,819* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $7.2B | $4.4B |
| Total Claims | 398,000 | 1,560,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 28.6%* | 35.2% |
| Generic Available | No | No |
| Condition | Cancer | Autoimmune Diseases |
| Total Beneficiaries | 82,000 | 245,000 |
Dupixent costs 84% less per claim than Keytruda ($2819.00 vs $18176.00). Neither drug has a generic alternative available. Total Medicare spending: Keytruda at $7.2B vs Dupixent at $4.4B.